UK slaps Pfizer with record £84.2m fine for unfair drug pricing
Pfizer and Flynn Pharma have been fined nearly £90 million by the UK’s Competition and Markets Authority (CMA) for deliberately unbranding an anti-epilepsy drug to enable excessive price hikes.
Read More
